Avtozma, which is Celltrion’s twelfth biosimilar to be approved by the EC, is a recombinant humanised monoclonal antibody ...
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European ...
South Korean firm Celltrion announced that the European Commission (EC) has granted marketing authorization for Avtozma ...
Hosted on MSN6d
EC authorises Celltrion’s Avtozma for multiple indicationsCelltrion has secured marketing authorisation from the European Commission (EC) for Avtozma (CT-P47), a biosimilar to Chugai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback